## Insecticides India Ltd. - Comprehensive Stock Analysis

**1. Company Overview:**

Insecticides India Ltd. is an agrochemical company operating in the Indian pesticides/agrochemicals industry.  Its business model centers around the manufacturing and distribution of agrochemicals (technicals and formulations), biological products, and household products.  The company boasts a wide distribution network, reaching over 70,000 dealers and retailers across India, and exports to over 22 countries.  Its recent launch of four new products signifies an effort to strengthen its market position.  While it holds a significant presence in the Indian market, its global reach is relatively limited compared to larger multinational players.

**2. Key Financial Metrics:**

* **Market Cap:** ₹ 2,171 Cr.
* **Current Price:** ₹ 734
* **High/Low (52-week):** ₹ 1,085 / ₹ 460
* **P/E Ratio:** 16.6
* **Book Value:** ₹ 377
* **Price-to-Book (P/B) Ratio:** 1.95 (₹734/₹377)
* **Dividend Yield:** 0.41%
* **ROCE:** 13.0%
* **ROE:** 10.5%
* **Face Value:** ₹ 10.0


**3. Strengths and Weaknesses:**

**Strengths:**

* Extensive distribution network providing strong market access.
* Recent product launches aimed at boosting market share.
* Relatively low debt levels (almost debt-free).
* Established presence in the Indian agrochemical market.
* Diversified product portfolio (insecticides, herbicides, fungicides, biologicals).


**Weaknesses:**

* Relatively low ROE and ROCE compared to some peers.
* Poor sales growth in recent years (especially TTM).
* Low R&D expenditure as a percentage of revenue, potentially hindering long-term innovation.
* Dependence on the Indian market, limiting diversification and growth potential.
*  Negative TTM sales growth indicates potential challenges in the market.


**4. Performance Trends:**

Detailed quarterly and annual data is unavailable without parsing the provided HTML.  However, the available data points to inconsistent performance. While the company shows some positive growth metrics over longer periods (10 and 5 years), the recent trends (3-year and TTM) reveal slowing sales growth and fluctuating profitability.  A thorough analysis of the HTML data is crucial to fully understand the performance trends and identify potential turning points.

**5. Growth Metrics:**

* **Sales CAGR (10Y):** 9%
* **Sales CAGR (5Y):** 11%
* **Sales CAGR (3Y):** 11%
* **Sales CAGR (TTM):** -4%
* **Profit CAGR (10Y):** 10%
* **Profit CAGR (5Y):** -4%
* **Profit CAGR (3Y):** 0%
* **Profit CAGR (TTM):** 109%
* **Stock Price CAGR (10Y):** 7%
* **Stock Price CAGR (5Y):** 19%
* **Stock Price CAGR (3Y):** 21%
* **Stock Price CAGR (1Y):** 6%
* **ROE (10Y):** 13%
* **ROE (5Y):** 11%
* **ROE (3Y):** 10%
* **ROE (TTM):**  Data unavailable without parsing HTML.

The growth metrics show a mixed picture. While long-term growth is relatively healthy, recent years have seen a significant slowdown in sales growth, although profit growth has spiked in the TTM period.  This requires further investigation to determine the sustainability of this recent profit surge.

**6. Comparison to Benchmarks:**

Compared to its peers (as provided), Insecticides India has a lower P/E ratio and market capitalization.  Its ROCE is also lower than the median.  However, its dividend yield is relatively higher.  A more detailed comparison requires a deeper dive into the financial statements of its peers and a consideration of their respective sizes and market positions.

**7. Stock Valuation:**

Based on the limited data, the P/E ratio of 16.6 appears relatively low compared to some peers, suggesting potential undervaluation. However, the low ROE and recent sales decline raise concerns. The P/B ratio of 1.95 is also a factor to consider.  A comprehensive valuation requires a detailed analysis of the financial statements and a discounted cash flow (DCF) model, which is not possible without parsing the HTML data.

**8. Recommendations and Confidence Levels:**

Due to the lack of complete financial data, assigning definitive recommendations with high confidence is not prudent.  A thorough analysis of the HTML data is necessary.  However, based on the available information:

* **Short-term (3-6 months):** Neutral.  The recent profit surge needs further investigation to determine its sustainability.  (Confidence Level: Low)
* **Medium-term (6-12 months):** Cautiously optimistic.  If the company can demonstrate sustained improvement in sales and profitability, the stock could appreciate. (Confidence Level: Low)
* **Long-term (1+ years):**  Potential for growth if the company can address its weaknesses, particularly in R&D and sales growth. (Confidence Level: Low)


**9. Final Verdict:**

Insecticides India Ltd. presents a mixed investment case. While it benefits from a strong distribution network and a relatively low debt level, concerns remain regarding its recent sales performance, low ROE, and limited R&D investment.  The provided data is insufficient for a definitive conclusion.  A comprehensive analysis of the detailed financial statements (available in the HTML) is crucial to accurately assess the company's financial health, growth prospects, and ultimately, its investment potential.  Until a more thorough analysis is conducted, the confidence level for any investment recommendation remains low.
